Individuals diagnosed with ulcerative colitis (UC) who displayed a elevated tumor-infiltrating immune cell (TIIC) signature score showed a more favorable reaction to anti-PD-L1 immunotherapy (refer to Figure 6B). Here, CD274 is linked to neoplasm.